Abstract | OBJECTIVES: RESEARCH DESIGN AND METHODS: Circulating SP-A concentration and metabolic variables (including insulin sensitivity by minimal model method, n = 89) were measured in 164 nonsmoking men. RESULTS: Circulating SP-A concentration was significantly higher among patients with glucose intolerance and type 2 diabetes than in subjects with normal glucose tolerance, even after adjustment for BMI, age, and smoking status (ex/never). The most significant differences were found in overweight and obese subjects with altered glucose tolerance (n = 59) who showed significantly increased serum SP-A concentrations (by a mean of 24%) compared with obese subjects with normal glucose tolerance (n = 58) (log SP-A 1.54 +/- 0.13 vs. 1.44 +/- 0.13; P < 0.0001). Insulin sensitivity (P = 0.003) contributed independently to 22% of SP-A variance among all subjects. In subjects with altered glucose tolerance, insulin sensitivity (P = 0.01) and fasting triglycerides (P = 0.02) contributed to 37% of SP-A variance. Controlling for serum creatinine or C-reactive protein in these models did not significantly change the results. CONCLUSIONS:
|
Authors | José Manuel Fernández-Real, Berta Chico, Masanori Shiratori, Yusuke Nara, Hiroki Takahashi, Wifredo Ricart |
Journal | Diabetes care
(Diabetes Care)
Vol. 31
Issue 5
Pg. 958-63
(May 2008)
ISSN: 1935-5548 [Electronic] United States |
PMID | 18285549
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Biomarkers
- Blood Glucose
- Pulmonary Surfactant-Associated Protein A
- Cholesterol
|
Topics |
- Biomarkers
(blood)
- Blood Glucose
(metabolism)
- Cholesterol
(blood)
- Diabetes Mellitus, Type 2
(blood)
- Glucose Intolerance
(blood)
- Humans
- Insulin Resistance
- Lung
(physiopathology)
- Male
- Pulmonary Surfactant-Associated Protein A
(blood)
- Reference Values
- Respiratory Distress Syndrome
(blood)
- White People
|